Patent · US Active

Use of targeted nitroxide agents in mitigating or treating radiation injury

US8822541B2 · kind B2 · utility

1Cited by
3References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 14, 2011
Grant dateSep 2, 2014
Priority date
Expiry dateDec 2, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compositions and related methods useful for free radical scavenging, with particular selectivity for mitochondria. The compounds comprise a nitroxide-containing group attached to a mitochondria-targeting group. The compounds can be cross-linked into dimers without loss of activity. Also provided herein are methods, for preventing, mitigating and treating damage caused by radiation. The method comprises delivering a compound, as described herein, to a patient in an amount and dosage regimen effective to prevent, mitigate or treat damage caused by radiation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.